Suppliers / F.I.S. – Fabbrica Italiana Sintetici

F.I.S. – Fabbrica Italiana Sintetici

Italy 2 duplicate records merged Updated 9 July 2026

F.I.S. – Fabbrica Italiana Sintetici is an API manufacturer based in Italy. It holds 41 active US drug master files. Its GMP standing is certified by EMA and ANVISA (Brazil). Its most recent recorded inspection, by US FDA, closed on 28 October 2022 as VAI.

41
active US DMFs
0
valid CEPs
7
registered plants 3 with an FDA FEI number
7
filings across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
3 of 3 confirmed
Inspections
8 of 8 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 28 October 2022 VAI US FDA
  • 6 May 2022 VAI US FDA
  • 17 September 2021 VAI US FDA
  • 5 July 2019 VAI US FDA
  • 6 July 2018 VAI US FDA
  • 1 June 2018 VAI US FDA
  • 17 February 2017 NAI US FDA
  • 25 February 2016 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
VICENZA, Italy Not on file
Italy, Italy 3008347496
Italy, Italy 3002808541
LONIGO, Italy Not on file
Italy, Italy 3002806961
TERMOLI, Italy Not on file

1 further sites are on record.

What they file, and where

Molecule Regulators Docs
Nitrofurantoin US FDA 3
Diazepam SFDA (Saudi Arabia), US FDA 2
Imatinib US FDA 2
Indomethacin US FDA 2
Pentazocine US FDA 2
Acetylcysteine US FDA 1
Carbamazepine US FDA 1
Chlordiazepoxide US FDA 1
Clobazam US FDA 1
Clomifene US FDA 1
Show all 30 molecules on file
Clonazepam US FDA 1
Clotrimazole US FDA 1
Diltiazem US FDA 1
Dorzolamide US FDA 1
Eletriptan US FDA 1
Enclomiphene US FDA 1
Estazolam US FDA 1
Flurazepam US FDA 1
Fluvastatin US FDA 1
Fosfomycin US FDA 1
Furosemide US FDA 1
Gabapentin US FDA 1
Lorazepam US FDA 1
Midazolam US FDA 1
Nebivolol US FDA 1
Nifedipine US FDA 1
Olopatadine US FDA 1
Oxazepam US FDA 1
Oxcarbazepine US FDA 1
Phloroglucinol SFDA (Saudi Arabia) 1

Also appears on these molecule pages

Show 7 more molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
MINSA (CR) 7 None
EMA None 1
ANVISA (Brazil) None 1

Comparing suppliers?

Choose your molecules and target markets. F.I.S. – Fabbrica Italiana Sintetici comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • 1 active litigation matter is on record.
  • The most recent inspection outcome was VAI, on 28 October 2022.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates